share_log

424B5: Prospectus

424B5: Prospectus

424B5：募资说明书
美股SEC公告 ·  09/03 09:21
Moomoo AI 已提取核心信息
Cingulate, a company listed on the Nasdaq Capital Market under the symbol 'CING', has filed a prospectus supplement on September 3, 2024, to update its previous offering terms. The supplement amends the prior prospectus dated January 13, 2023, and its subsequent supplements, to increase the amount of common stock the company is eligible to sell. Under the revised terms, Cingulate may now offer and sell shares with an aggregate offering price of up to $3,870,000 through H.C. Wainwright & Co., LLC, acting as the sales agent. This new limit is in addition to the $11,323,947.19 worth of common stock already sold under the previous prospectus. The public float of Cingulate's common stock was valued at over $40 million as of September 3, 2024, based on the closing price of $17.69 per share on August 16, 2024. The last reported sale price of Cingulate's common stock was $7.89 per share on August 30, 2024.
Cingulate, a company listed on the Nasdaq Capital Market under the symbol 'CING', has filed a prospectus supplement on September 3, 2024, to update its previous offering terms. The supplement amends the prior prospectus dated January 13, 2023, and its subsequent supplements, to increase the amount of common stock the company is eligible to sell. Under the revised terms, Cingulate may now offer and sell shares with an aggregate offering price of up to $3,870,000 through H.C. Wainwright & Co., LLC, acting as the sales agent. This new limit is in addition to the $11,323,947.19 worth of common stock already sold under the previous prospectus. The public float of Cingulate's common stock was valued at over $40 million as of September 3, 2024, based on the closing price of $17.69 per share on August 16, 2024. The last reported sale price of Cingulate's common stock was $7.89 per share on August 30, 2024.
Cingulate是一家在纳斯达克资本市场上市的公司，股票代码为'CING'，于2024年9月3日提交了一份招股说明书补充，以更新其先前的发行条款。该补充修订了于2023年1月13日发布的先前招股说明书及其后续补充，以增加公司有权出售的普通股金额。根据修订后的条款，Cingulate现在可以通过H.C. Wainwright & Co., LLC作为销售代理，提供和销售总额高达387万美元的股份。这一新限额是在之前招股说明书中已售出的价值11,323,947.19美元的普通股额外增加的。Cingulate的普通股公开流通价值于2024年9月3日超过4000万美元，根据2024年8月16日每股17.69美元的收盘价计算。Cingulate普通股的最后报道销售价格为2024年8月30日的每股7.89美元。
Cingulate是一家在纳斯达克资本市场上市的公司，股票代码为'CING'，于2024年9月3日提交了一份招股说明书补充，以更新其先前的发行条款。该补充修订了于2023年1月13日发布的先前招股说明书及其后续补充，以增加公司有权出售的普通股金额。根据修订后的条款，Cingulate现在可以通过H.C. Wainwright & Co., LLC作为销售代理，提供和销售总额高达387万美元的股份。这一新限额是在之前招股说明书中已售出的价值11,323,947.19美元的普通股额外增加的。Cingulate的普通股公开流通价值于2024年9月3日超过4000万美元，根据2024年8月16日每股17.69美元的收盘价计算。Cingulate普通股的最后报道销售价格为2024年8月30日的每股7.89美元。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息